Ultragenyx Pharmaceutical
RARE
RARE
250 hedge funds and large institutions have $9.36B invested in Ultragenyx Pharmaceutical in 2020 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 97 increasing their positions, 71 reducing their positions, and 16 closing their positions.
Holders
250
Holders Change
+45
Holders Change %
+21.95%
% of All Funds
4.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
61
Increased
97
Reduced
71
Closed
16
Calls
$59.6M
Puts
$16.3M
Net Calls
+$43.4M
Net Calls Change
+$40.4M
Top Buyers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$1.31B |
2 |
2
BlackRock
New York
|
$732M |
3 |
3
Capital Research Global Investors
Los Angeles,
California
|
$1.01B |
4 |
BBA
4
Baker Bros. Advisors
New York
|
$61.5M |
5 |
5
Goldman Sachs
New York
|
$121M |